logo

RXST

RxSight·NASDAQ
--
--(--)
--
--(--)
1.71 / 10
Underperform

Corporate fundamentals are rated weak (1.7/10). Key concerns include negative asset-to-market and revenue-to-market values, low profitability margins, and suboptimal cash flow positioning. These elements collectively suggest financial stress and caution investors against aggressive exposure.

Fundamental(1.71)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value-0.67
Score2/3
Weight-0.43%
1M Return0.09%
ROA (%)
Value-9.50
Score1/3
Weight2.95%
1M Return-0.54%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight8.15%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight11.51%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight19.87%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-12.67
Score1/3
Weight2.95%
1M Return-0.54%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight9.19%
1M Return-1.95%
Asset-MV
Value-0.50
Score0/3
Weight15.40%
1M Return-3.57%
Cash-MV
Value-0.07
Score1/3
Weight21.83%
1M Return-5.64%
Net profit / Total profit (%)
Value100.21
Score2/3
Weight8.56%
1M Return-1.71%
Is RXST fundamentally strong?
  • RXST scores 1.71/10 on fundamentals and holds a Premium valuation at present. Backed by its -10.69% ROE, -25.15% net margin, -10.64 P/E ratio, 1.24 P/B ratio, and -8.64% earnings growth, these metrics solidify its Underperform investment rating.